Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZYNE | TEVA | BBIO | RDY | SUPN |
| Company | Zynerba Pharma CS | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.2600 | 28.40 | 74.40 | 14.13 | 44.94 |
| High | 1.3400 | 28.68 | 74.86 | 14.21 | 45.88 |
| Low | 1.2600 | 28.00 | 72.38 | 14.10 | 44.51 |
| Latest | 1.3000 | 28.46 | 73.64 | 14.19 | 45.68 |
| Change | +0.0300 | +0.05 | -1.12 | +0.05 | +0.58 |
| % Change | +2.36% | +0.18% | -1.50% | +0.35% | +1.29% |
| Volume | 862,700 | 8,529,500 | 1,938,800 | 816,200 | 458,500 |
| 20-Day Average Volume | 1,093,995 | 11,411,940 | 2,113,020 | 939,170 | 782,905 |
| Previous Close | 1.2700 | 28.41 | 74.76 | 14.14 | 45.10 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3012 | 25.69 | 68.54 | 13.92 | 45.24 |
| 20-Day Raw Stochastic | 53.49% | 95.66% | 90.34% | 98.17% | 47.45% |
| 20-Day Relative Strength | 62.80 | 77.59 | 68.90 | 54.16 | 46.27 |
| Weighted Alpha | -35.90 | +77.30 | +176.98 | -1.82 | +28.90 |
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | 24% Sell | 56% Buy |
| Previous Opinion | 80% Buy | 100% Buy | 100% Buy | 40% Sell | 40% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 56% Sell | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.17% since 10/03/23 | +5.84% since 11/28/25 | +2.26% since 11/28/25 | +1.00% since 11/28/25 | +0.20% since 11/28/25 |
| Low | 1.1850 on 10/04/23 | 26.46 on 12/01/25 | 71.07 on 12/01/25 | 13.94 on 12/01/25 | 44.09 on 12/02/25 |
| High | 1.3400 on 10/10/23 | 28.68 on 12/05/25 | 75.04 on 12/04/25 | 14.20 on 12/05/25 | 45.88 on 12/05/25 |
| 1-Month | |||||
| %Chg | -1.52% since 09/08/23 | +15.69% since 11/05/25 | +17.52% since 11/05/25 | +5.90% since 11/05/25 | -3.04% since 11/05/25 |
| Low | 1.1850 on 10/04/23 | 23.61 on 11/07/25 | 60.55 on 11/07/25 | 13.37 on 11/06/25 | 44.05 on 11/18/25 |
| High | 1.4000 on 09/15/23 | 28.68 on 12/05/25 | 75.04 on 12/04/25 | 14.20 on 12/05/25 | 47.69 on 11/06/25 |
| 3-Month | |||||
| %Chg | +293.70% since 07/10/23 | +50.18% since 09/05/25 | +37.95% since 09/05/25 | -1.05% since 09/05/25 | -0.70% since 09/05/25 |
| Low | 0.2500 on 07/11/23 | 18.21 on 09/25/25 | 48.78 on 09/25/25 | 13.14 on 10/29/25 | 43.11 on 11/05/25 |
| High | 1.4000 on 09/15/23 | 28.68 on 12/05/25 | 75.04 on 12/04/25 | 15.06 on 09/17/25 | 57.65 on 10/30/25 |
| 6-Month | |||||
| %Chg | +225.00% since 04/10/23 | +64.99% since 06/05/25 | +92.07% since 06/05/25 | -8.63% since 06/05/25 | +41.25% since 06/05/25 |
| Low | 0.2500 on 07/11/23 | 14.99 on 08/01/25 | 38.26 on 06/06/25 | 13.14 on 10/29/25 | 30.83 on 06/25/25 |
| High | 1.4000 on 09/15/23 | 28.68 on 12/05/25 | 75.04 on 12/04/25 | 16.17 on 06/12/25 | 57.65 on 10/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 70,121 | 32,642,480 | 14,191,090 | 11,847,656 | 2,619,246 |
| Shares Outstanding, K | 53,939 | 1,146,960 | 192,709 | 834,930 | 57,339 |
| Annual Sales | 0 | 16,544,000,000 | 221,900,000 | 3,811,000,000 | 661,820,000 |
| Annual Net Income | -35,040,000 | -1,639,000,000 | -535,760,000 | 663,000,000 | 73,870,000 |
| Last Quarter Sales | 0 | 4,480,000,000 | 120,700,000 | 1,012,590,000 | 192,100,000 |
| Last Quarter Net Income | -10,780,000 | 433,000,000 | -182,740,000 | 165,280,000 | -45,120,000 |
| 60-Month Beta | 1.32 | 0.67 | 1.26 | 0.39 | 0.71 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/14/23 | 0.78 on 11/05/25 | -0.95 on 10/29/25 | 0.19 on 10/24/25 | 1.01 on 11/04/25 |
| Latest Earnings Date | 11/13/23 | 11/05/25 | 10/29/25 | 01/22/26 | 11/04/25 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.01 | 0.00 | 17.46 | 21.17 |